Literature DB >> 27469027

Non-human primates in HIV research: Achievements, limits and alternatives.

Thalía Garcia-Tellez1, Nicolas Huot2, Mickaël J Ploquin3, Philippe Rascle4, Beatrice Jacquelin5, Michaela Müller-Trutwin6.   

Abstract

An ideal model for HIV-1 research is still unavailable. However, infection of non-human primates (NHP), such as macaques, with Simian Immunodeficiency Virus (SIV) recapitulates most virological, immunological and clinical hallmarks of HIV infection in humans. It has become the most suitable model to study the mechanisms of transmission and physiopathology of HIV/AIDS. On the other hand, natural hosts of SIV, such as African green monkeys and sooty mangabeys that when infected do not progress to AIDS, represent an excellent model to elucidate the mechanisms involved in the capacity of controlling inflammation and disease progression. The use of NHP-SIV models has indeed enriched our knowledge in the fields of: i) viral transmission and viral reservoirs, ii) early immune responses, iii) host cell-virus interactions in tissues, iv) AIDS pathogenesis, v) virulence factors, vi) prevention and vii) drug development. The possibility to control many variables during experimental SIV infection, together with the resemblance between SIV and HIV infections, make the NHP model the most appropriate, so far, for HIV/AIDS research. Nonetheless, some limitations in using these models have to be considered. Alternative models for HIV/AIDS research, such as humanized mice and recombinant forms of HIV-SIV viruses (SHIV) for NHP infection, have been developed. The improvement of SHIV viruses that mimic even better the natural history of HIV infection and of humanized mice that develop a greater variety of human immune cell lineages, is ongoing. None of these models is perfect, but they allow contributing to the progress in managing or preventing HIV infection. Copyright Â
© 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AIDS; Animal models; HIV; Non-human primates; SIV

Mesh:

Year:  2016        PMID: 27469027     DOI: 10.1016/j.meegid.2016.07.012

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  20 in total

Review 1.  The Promise of Long-Acting Antiretroviral Therapies: From Need to Manufacture.

Authors:  Howard E Gendelman; JoEllyn McMillan; Aditya N Bade; Benson Edagwa; Bhavesh D Kevadiya
Journal:  Trends Microbiol       Date:  2019-04-10       Impact factor: 17.079

Review 2.  Natural pathology of the captive chimpanzee (Pan troglodytes): A 35-year review.

Authors:  Shyamesh Kumar; Hannah Laurence; Michael A Owston; R Mark Sharp; Priscilla Williams; Robert E Lanford; Gene B Hubbard; Edward J Dick
Journal:  J Med Primatol       Date:  2017-05-23       Impact factor: 0.667

3.  Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor.

Authors:  David A Spencer; Delphine C Malherbe; Néstor Vázquez Bernat; Monika Ádori; Benjamin Goldberg; Nicholas Dambrauskas; Heidi Henderson; Shilpi Pandey; Tracy Cheever; Philip Barnette; William F Sutton; Margaret E Ackerman; James J Kobie; D Noah Sather; Gunilla B Karlsson Hedestam; Nancy L Haigwood; Ann J Hessell
Journal:  J Immunol       Date:  2021-01-20       Impact factor: 5.422

4.  NK cell spatial dynamics and IgA responses in gut-associated lymphoid tissues during SIV infections.

Authors:  Philippe Rascle; Cyril Planchais; Béatrice Jacquelin; Marie Lazzerini; Vanessa Contreras; Caroline Passaes; Asier Saez-Cirion; Hugo Mouquet; Nicolas Huot; Michaela Müller-Trutwin
Journal:  Commun Biol       Date:  2022-07-07

Review 5.  HIV Latency in Myeloid Cells: Challenges for a Cure.

Authors:  Alisha Chitrakar; Marta Sanz; Sanjay B Maggirwar; Natalia Soriano-Sarabia
Journal:  Pathogens       Date:  2022-05-24

Review 6.  Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.

Authors:  Ignacio Rodríguez-Izquierdo; Daniel Sepúlveda-Crespo; Jose María Lasso; Salvador Resino; Ma Ángeles Muñoz-Fernández
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-01-12

7.  APOBEC3F Constitutes a Barrier to Successful Cross-Species Transmission of Simian Immunodeficiency Virus SIVsmm to Humans.

Authors:  Rayhane Nchioua; Dorota Kmiec; Amit Gaba; Christina M Stürzel; Tyson Follack; Stephen Patrick; Andrea Kirmaier; Welkin E Johnson; Beatrice H Hahn; Linda Chelico; Frank Kirchhoff
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

Review 8.  Evolution and Diversity of Immune Responses during Acute HIV Infection.

Authors:  Samuel W Kazer; Bruce D Walker; Alex K Shalek
Journal:  Immunity       Date:  2020-11-17       Impact factor: 31.745

9.  Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques.

Authors:  Widade Ziani; Anya Bauer; Hong Lu; Xiaolei Wang; Xueling Wu; Katharine J Bar; Hui Li; Dongfang Liu; George M Shaw; Ronald S Veazey; Huanbin Xu
Journal:  J Virol       Date:  2021-04-12       Impact factor: 6.549

10.  CD32+CD4+ T Cells Sharing B Cell Properties Increase With Simian Immunodeficiency Virus Replication in Lymphoid Tissues.

Authors:  Nicolas Huot; Philippe Rascle; Cyril Planchais; Vanessa Contreras; Caroline Passaes; Roger Le Grand; Anne-Sophie Beignon; Etienne Kornobis; Rachel Legendre; Hugo Varet; Asier Saez-Cirion; Hugo Mouquet; Beatrice Jacquelin; Michaela Müller-Trutwin
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.